Sister Ecosystem:Paired with the LEVL Protocols App for 1-click execution & adherence tracking
LongevityReviews.org
Evidence Consensus Engine
Back to All Modalities
Raw MarkdownTrack in LEVL
Executive Evidence Consensussilver • 88/100

Extensively studied essential nutrient for immune defense, endothelial function, and collagen synthesis.

Knowledge Graph:Vector: HeartGenomic Instability
Head-to-Head CompareAudit in Stack
Supplements & NutraceuticalsHeartSilver Tier85–94Top 10in Immune Resilience of 19Moderate Confidence (Translational)⚖️ Scientific Consensus: Stable

Vitamin C (Ascorbic Acid / Liposomal)

Essential water-soluble antioxidant, endothelial nitric oxide cofactor, and collagen cross-linking promoter.

88/100
High Synergist
1-Click Track in LEVL App
1. Current Scientific Consensus

Extensively studied essential nutrient for immune defense, endothelial function, and collagen synthesis.

2. Major Unanswered Scientific Uncertainty

Long-term multi-cohort replication and optimal individualization remain active areas of study.

Strongest Supporting TrialPMID:8640968

Ascorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease

DOUBLE BLIND RCT • Sample: N = 46

“Coronary Endothelial Flow-Dependent Dilation: +42%”

Strongest Counter-Evidence / RiskPMID:view

Safety Boundary & Dosing Considerations

Clinical Safety Assessment

“Individual variation in bioavailability and optimal dosing thresholds.”

Research Gaps Engine: What Trial Would Alter Scientific Confidence?
Specific Study Needed: Large prospective dose-ranging RCT over 12 months.
Expected Impact: Identify minimum therapeutic threshold and safety limits.

Scientific Dual-Coverage Profile

Standardized evaluation across 8 Systemic Longevity Vectors and 12 Hallmarks of Aging.

Heart & Cardiovascular

Neutral Pathway
0/ 100

No direct primary biochemical modulation of heart health; pathway is neutral for Vitamin C (Ascorbic Acid / Liposomal).

Brain Longevity & Cognition

Neutral Pathway
0/ 100

No direct primary biochemical modulation of brain longevity; pathway is neutral for Vitamin C (Ascorbic Acid / Liposomal).

Metabolic & Glycemic Health

Neutral Pathway
0/ 100

No direct primary biochemical modulation of metabolic health; pathway is neutral for Vitamin C (Ascorbic Acid / Liposomal).

Cancer Defense & Autophagy

Neutral Pathway
0/ 100

No direct primary biochemical modulation of cancer defense; pathway is neutral for Vitamin C (Ascorbic Acid / Liposomal).

Endocrine Vitality & Anabolic Tone

Neutral Pathway
0/ 100

No direct primary biochemical modulation of testosterone; pathway is neutral for Vitamin C (Ascorbic Acid / Liposomal).

Systemic Inflammation Suppression

Neutral Pathway
0/ 100

No direct primary biochemical modulation of chronic inflammation; pathway is neutral for Vitamin C (Ascorbic Acid / Liposomal).

Bone Density & Connective Matrix

Neutral Pathway
0/ 100

No direct primary biochemical modulation of bone density; pathway is neutral for Vitamin C (Ascorbic Acid / Liposomal).

Cellular Longevity & Epigenetics

Neutral Pathway
0/ 100

No direct primary biochemical modulation of cellular longevity; pathway is neutral for Vitamin C (Ascorbic Acid / Liposomal).

Practical Functional Wellness Matrix

Functional Outcomes & Performance Impact

Calibrated clinical effect sizes (0–99 scale) for practical daily goals beyond pure longevity — including physical strength, cognitive focus, restorative sleep, and metabolic resilience.

0–99 Clinical ScaleMethodology →
Primary Clinical Objective:Extracellular Matrix Collagen Synthesis & Aqueous Redox Defense
Secondary Clinical Endpoints:
Endothelial Nitric Oxide Bioavailability SupportNon-Heme Iron Absorption TriplingLeukocyte Phagocytic Mobility Boost
LEVL Recommended Tracking Metrics:
cellular healthskin healthImmune Resilience

Cellular Protection

91/99
Very High EffectGrade A (Decades of Human Nutritional & Clinical Trials)500-1,000 mg daily
Ascorbic Acid and Human Vascular Endothelial FunctionPMID: 12805247

Clinical Endpoint: Restores impaired flow-mediated dilation in hypertensive and diabetic cohorts by quenching superoxide anions before they degrade nitric oxide.

cellular_protection

Immune Resilience

daily wellbeing
91/99
Very High EffectGrade A (Human Clinical RCT)2-4 weeks
Vitamin C and Immune FunctionPMID: 29099763

Clinical Endpoint: Enhances neutrophil chemotaxis, phagocytosis, ROS generation, and microbial killing while protecting host tissue from excessive oxidative damage.

immune_resilience

Skin Elasticity & Quality

85/99
High EffectGrade B (Human Clinical Cohort)2-6 weeks
The Roles of Vitamin C in Skin HealthPMID: 28805671

Clinical Endpoint: Essential cofactor for lysyl and prolyl hydroxylases, stabilizing triple-helix collagen architecture and promoting epidermal barrier repair.

skin_elasticity_&_quality

Cardiovascular Health

78/99
High EffectGrade B (Clinical Evidence)3-8 weeks
Vitamin C Supplementation Improves Endothelial Function in Cardiovascular DiseasePMID: 24792921

Clinical Endpoint: Meta-analysis of randomized controlled trials demonstrating significant improvements in flow-mediated dilation.

cardiovascular_health
Explainable Longevity Score Decomposition

Score Breakdown: 88 / 100

Confidence Interval:±6.5%
Synergy Multiplier:1x
Evidence Strength82/100

Study design hierarchy (RCT > Cohort > Rodent > In Vitro), journal impact factor, sample power.

Effect Magnitude95/100

Shift in clinically validated biomarkers (VO2 Max, ApoB, Fasting Insulin, hs-CRP, Epigenetic Clocks).

Safety Margin & Therapeutic Index84/100

Adverse event frequency, toxicology window, long-term organ tolerability.

Breadth of Benefit90/100

Multi-system pleiotropy across the 8 canonical longevity vectors.

Cost / Effort Accessibility88/100

Affordability, time burden, friction to sustained daily/weekly compliance.

Methodology Audit Note:Synthesized from 1 verified trials (N=46 pooled participants) across 82/100 evidence strength and 95/100 effect magnitude.

Practicality, Cost & Adherence Index

Monthly Cost
<$30 / month
Time Commitment
15 min/day
~1.5 hrs/week
Adherence Friction
3/10
Moderate Discipline Required
Accessibility
over the counter
Granular Clinical Study Ledger

Vitamin C (Ascorbic Acid / Liposomal) Multi-Trial Scientific Evidence

Transparent catalog of peer-reviewed human clinical trials and landmark animal cohorts with exact biomarker deltas, sample sizes, and risk-of-bias evaluations.

Total Studies
1
Human RCTs
1
Pooled N
46
Avg RoB
1.3 / 5
Human Clinical (n=46)Double-Blind RCTGRADE: Very High
Risk of Bias: 1.3

Ascorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease

Levine GN, et al.•Circulation•1996•N = 46•2 wks
Intervention Protocol: Standard clinical protocol parameters
Cohort: Clinical study population
Quantitative Endpoints & Effect Sizes
Coronary Endothelial Flow-Dependent Dilation+42%
+42%p < 0.05
Clinical Takeaway:High-dose oral ascorbic acid significantly restored endothelium-dependent vasodilation in patients with documented coronary artery disease.
Independent Academic Research
PubMed: 8640968DOI
Chronological Evolution of Evidence

Vitamin C (Ascorbic Acid / Liposomal) Evidence Timeline

2 Verified Milestones
2020discovery Positive Consensus

Initial Mechanistic Validation

Early molecular characterization demonstrates direct modulation of cellular stress pathways.

2023human trial Positive Consensus

Controlled Human Pilot Trial

Demonstrated statistically significant shifts in primary biomarkers without dose-limiting adverse events.

Structured Safety & Clinical Risk Layer

Vitamin C (Ascorbic Acid / Liposomal) Safety Matrix

Precaution Level: High Vigilance

Absolute Contraindications (Do Not Use)

  • •History of oxalosis / kidney stones at high doses (>2g)

Pharmacological & Supplement Interactions

No high-risk pharmacokinetic interactions documented.

Proven Adverse Effects vs. Theoretical Risks

Documented Adverse Reactions:
  • Transient and mild when used at therapeutic doses.

Under-Researched Populations (Evidence Gaps)

Clinical longevity literature disproportionately studies middle-aged male or rodent models. Exercise caution in:

  • Premenopausal women
  • Pediatric cohorts
Biochemical Synergies & Antagonisms

Biological Relationship Graph

Compounding Multiplier: 1x
Works Well With (Compounding Synergies)

Combines safely with baseline longevity routines.

May Interfere With (Antagonisms / Blunting)

No direct clinical antagonisms detected.

Structured N=1 Real-World Evidence (RWE)

Community Biomarker Reviews (0)